[ad_1]
Serbia could soon start production of the Russian vaccine “Sputnik V” and, as Health Minister Zlatibor Loncar announced, more will be known about it by the end of the week, because a team of Russian experts announced a visit to the Institute “Torlak ” Thursday.
According to the minister, this would mean that Serbia could produce the vaccine both for itself and for the needs of the region, and the process of the first phase could start in two to three months.
– By the first phase, I mean that most of the finished substance comes here, and then we have to make a small part, pack it, prepare it for use, label it and do all the necessary checks – Lončar said.
As he said this morning, after that first phase, and at about 6:7 in Torlak, production of the corona vaccine could begin.
“That would mean we would have enough vaccines for ourselves and for the entire region,” Lončar said after receiving the second dose of the vaccine this morning.
During the month of January, our delegation visited Moscow, that is, “Generium Pharmaceutical”, which produces the “Sputnik V” vaccine, and on that occasion a visit to “Torlak” was arranged.
Epidemiologist and crisis staff member Prof. Dr. Branislav Tiodorović tells “Blic” that the production of the Russian vaccine would be very important to our country in every way, and recalls that “Torlak” used to be a world – famous vaccine manufacturer.
– If production starts, it would be a great gain for both the state and the people, that is, the population would have a very good vaccine at their disposal, which we could further improve with the manufacturer using their capabilities. In this way, the vaccine would be much more accessible, we would have our own production and it would surely mean a lot for the country’s economy if production together with our strategic partners in Russia were to rise to the level that we are willing to offer. to the world – says by “Blic” “Dr. Tiodorović.
Remember that “Torlak” used to be a very famous manufacturer of all the vaccines in the world.
– Therefore, we hope that we will fulfill the conditions and that we will make an extremely important step through a strategic partnership – says Dr. Tiodorović.
Institute Director: “Torlak” is known for its quality
The director of the Torlak Institute, Dr. Vera Stoiljković, recently said in an interview with Blic that the Institute, with its conscientious and responsible business, recognizable quality and many years of experience, intends to maintain the status of an internationally recognized institution. in the field of diagnostics. through its national reference laboratories and vaccines, and serum, through both existing and new vaccines.
– In addition to the resources that the Torlak Institute has, which relate to the premises, equipment and professional staff, by adjusting the available space and acquiring the appropriate equipment necessary for technology transfer, the Torlak Institute could establish concrete cooperation in the near future. Russian partners in connection with production, that is, they start the production of such a vaccine. The Institute “Torlak” awaits the visit of a partner from Russia, who will continue with the agreements on the transfer of technology for the production of the vaccine Gam-Covid-Vak – stated Dr. Stoiljković for “Blic”.
As the director also explains, with her almost one hundred years of experience, “Torlak” has confirmed countless times the quality of its products and services and the need for existence is absolutely recognized and proven in the situation in which we find ourselves in relation to the kovid. pandemic 19.
VIDEO: “Sputnik V” vaccines delivered to Torlak
[ad_2]
